{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:20:31Z","timestamp":1778620831108,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004772","name":"Natural Science Foundation of Ningxia Province","doi-asserted-by":"publisher","award":["2024AAC03678"],"award-info":[{"award-number":["2024AAC03678"]}],"id":[{"id":"10.13039\/501100004772","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.intimp.2025.114033","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T14:11:41Z","timestamp":1736604701000},"page":"114033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A VZV-gE subunit vaccine decorated with mPLA elicits protective cellular immmune responses against varicella-zoster virus"],"prefix":"10.1016","volume":"147","author":[{"given":"Tingting","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangxia","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbao","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5838-3257","authenticated-orcid":false,"given":"Jianhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.intimp.2025.114033_b0005","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S1473-3099(19)30163-X","article-title":"Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis","volume":"19","author":"Dagnew","year":"2019","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2025.114033_b0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4161\/hv.34363","article-title":"Reducing the burden of Herpes Zoster in Italy","volume":"11","author":"Gabutti","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.intimp.2025.114033_b0015","doi-asserted-by":"crossref","first-page":"1419634","DOI":"10.3389\/fimmu.2024.1419634","article-title":"A nanoparticle vaccine displaying varicella-zoster virus gE antigen induces a superior cellular immune response than a licensed vaccine in mice and non-human primates","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"issue":"Pt B","key":"10.1016\/j.intimp.2025.114033_b0020","article-title":"Immune response of C57BL\/6J mice to herpes zoster subunit vaccines formulated with nanoemulsion-based and liposome-based adjuvants","volume":"101","author":"He","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2025.114033_b0025","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1086\/605611","article-title":"Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine","volume":"200","author":"Weinberg","year":"2009","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.intimp.2025.114033_b0030","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.1021\/acs.molpharmaceut.3c00536","article-title":"Liposome Vaccine for Active Regulation of Cellular and Humoral Immunity","volume":"20","author":"Luo","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.intimp.2025.114033_b0035","doi-asserted-by":"crossref","first-page":"8029","DOI":"10.2147\/IJN.S464720","article-title":"Heterologous Prime-Boost Immunization Strategies Using Varicella-Zoster Virus gE mRNA Vaccine and Adjuvanted Protein Subunit Vaccine Triggered Superior Cell Immune Response in Middle-Aged Mice","volume":"19","author":"Li","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.intimp.2025.114033_b0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41541-022-00467-z","article-title":"An adjuvanted zoster vaccine elicits potent cellular immune responses in mice without QS21","volume":"7","author":"Nam","year":"2022","journal-title":"npj Vaccines"},{"issue":"13","key":"10.1016\/j.intimp.2025.114033_b0045","doi-asserted-by":"crossref","first-page":"e2310886","DOI":"10.1002\/adma.202310886","article-title":"A Synergistic Lipid Nanoparticle Encapsulating mRNA Shingles Vaccine Induces Potent Immune Responses and Protects Guinea Pigs from Viral Challenges","volume":"36","author":"Cheng","year":"2024","journal-title":"Adv. Mater."},{"issue":"16","key":"10.1016\/j.intimp.2025.114033_b0050","first-page":"1576","article-title":"Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults","volume":"373","author":"Fielding","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.intimp.2025.114033_b0055","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.vaccine.2015.09.073","article-title":"Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults","volume":"34","author":"Chlibek","year":"2016","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.intimp.2025.114033_b0060","doi-asserted-by":"crossref","first-page":"11087","DOI":"10.1021\/acsnano.9b03660","article-title":"Multilamellar Vaccine Particle Elicits Potent Immune Activation with Protein Antigens and Protects Mice against Ebola Virus Infection","volume":"13","author":"Fan","year":"2019","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.intimp.2025.114033_b0065","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3390\/pharmaceutics14050973","article-title":"Ionizable Lipid Nanoparticles Enhanced the Synergistic Adjuvant Effect of CpG ODNs and QS21 in a Varicella Zoster Virus Glycoprotein E Subunit Vaccine","volume":"14","author":"Luan","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.intimp.2025.114033_b0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.addr.2020.06.002","article-title":"Lipid nanoparticles for nucleic acid delivery: Current perspectives","volume":"154\u2013155","author":"Samaridou","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2025.114033_b0075","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1038\/s41467-024-49546-w","article-title":"A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection","volume":"15","author":"Zhong","year":"2024","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.intimp.2025.114033_b0080","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1021\/acscentsci.1c00596","article-title":"Polymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular Immunity","volume":"7","author":"Volpatti","year":"2021","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.intimp.2025.114033_b0085","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.actbio.2023.09.013","article-title":"Monophosphoryl lipid A-assembled nanovaccines enhance tumor immunotherapy","volume":"171","author":"Li","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.intimp.2025.114033_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114022","article-title":"Mechanisms of immune response to inorganic nanoparticles and their degradation products","volume":"180","author":"Mohammapdour","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.intimp.2025.114033_b0095","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.it.2017.10.002","article-title":"Improving Vaccine and Immunotherapy Design Using Biomaterials","volume":"39","author":"Bookstaver","year":"2018","journal-title":"Trends Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2025.114033_b0100","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.1021\/acsnano.3c04471","article-title":"A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists","volume":"18","author":"Baljon","year":"2024","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.intimp.2025.114033_b0105","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.1021\/acsnano.2c05800","article-title":"Translatable Drug-Loaded Iron Oxide Nanophore Sensitizes Murine Melanoma Tumors to Monoclonal Antibody Immunotherapy","volume":"17","author":"Stater","year":"2023","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.intimp.2025.114033_b0110","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1016\/j.apsb.2022.05.032","article-title":"Spatio-temporal delivery of both intra- and extracellular toll-like receptor agonists for enhancing antigen-specific immune responses","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.intimp.2025.114033_b0115","article-title":"Monophosphoryl lipid A-adjuvanted nucleoprotein-neuraminidase nanoparticles improve immune protection against divergent influenza viruses","volume":"47","author":"Wang","year":"2023","journal-title":"Nanomedicine"},{"issue":"7","key":"10.1016\/j.intimp.2025.114033_b0120","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.3390\/molecules23071583","article-title":"Recent Advances in Toll Like Receptor-Targeting Glycoconjugate Vaccines","volume":"23","author":"Li","year":"2018","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.intimp.2025.114033_b0125","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3390\/pharmaceutics14020423","article-title":"Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases","volume":"14","author":"Yang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.intimp.2025.114033_b0130","doi-asserted-by":"crossref","first-page":"3974127","DOI":"10.1155\/2019\/3974127","article-title":"Chemical and Immunological Characteristics of Aluminum-Based, Oil-Water Emulsion, and Bacterial-Origin Adjuvants","volume":"2019","author":"Marti\u00f1\u00f3n","year":"2019","journal-title":"J. Immunol. Res."},{"issue":"20","key":"10.1016\/j.intimp.2025.114033_b0135","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.1158\/0008-5472.CAN-19-0381","article-title":"Nanoparticle Encapsulation of Synergistic Immune Agonists Enables Systemic Codelivery to Tumor Sites and IFN\u03b2-Driven Antitumor Immunity","volume":"79","author":"Atukorale","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2025.114033_b0140","doi-asserted-by":"crossref","unstructured":"Alving CR, Peachman KK, Matyas GR, et al. Army Liposome Formulation (ALF) family of vaccine adjuvants. Expert. Rev. Vaccines., 2020, 19(3): 279-292. [54] Lang S, Huang X. Carbohydrate Conjugates in Vaccine Developments. Front. Chem., 2020, 8: 284.","DOI":"10.1080\/14760584.2020.1745636"},{"issue":"7","key":"10.1016\/j.intimp.2025.114033_b0145","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1021\/acs.nanolett.9b00030","article-title":"Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy","volume":"19","author":"Zhang","year":"2019","journal-title":"Nano Lett."},{"issue":"11","key":"10.1016\/j.intimp.2025.114033_b0150","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3390\/ph14111173","article-title":"Brief on Recent Application of Liposomal Vaccines for Lower Respiratory Tract Viral Infections: From Influenza to COVID-19 Vaccines","volume":"14","author":"Attia","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"9","key":"10.1016\/j.intimp.2025.114033_b0155","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.3390\/pharmaceutics13091491","article-title":"Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration","volume":"13","author":"Navarro-Partida","year":"2021","journal-title":"Pharmaceutics"},{"issue":"20","key":"10.1016\/j.intimp.2025.114033_b0160","doi-asserted-by":"crossref","first-page":"e2006007","DOI":"10.1002\/adma.202006007","article-title":"Development of a Cancer Vaccine Using In Vivo Click-Chemistry-Mediated Active Lymph Node Accumulation for Improved Immunotherapy","volume":"33","author":"Qin","year":"2021","journal-title":"Adv. Mater."},{"issue":"8","key":"10.1016\/j.intimp.2025.114033_b0165","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1021\/acs.molpharmaceut.1c00447","article-title":"Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines","volume":"18","author":"Chatzikleanthous","year":"2021","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.intimp.2025.114033_b0170","first-page":"82","article-title":"The biological applications of inorganic nanoparticle drug carriers","volume":"1","author":"Zhao","year":"2015","journal-title":"Chem. Nano. Mat."},{"issue":"15","key":"10.1016\/j.intimp.2025.114033_b0175","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.vaccine.2019.02.048","article-title":"Efficient induction of cell-mediated immunity to varicella-zoster virus glycoprotein E co-lyophilized with a cationic liposome-based adjuvant in mice","volume":"37","author":"Wui","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2025.114033_b0180","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.addr.2020.06.020","article-title":"Delivery of drugs, proteins, and nucleic acids using inorganic nanoparticles","volume":"156","author":"Luther","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"43","key":"10.1016\/j.intimp.2025.114033_b0185","doi-asserted-by":"crossref","first-page":"13521","DOI":"10.1002\/anie.201708190","article-title":"Evolution of the Ligand Shell Morphology during Ligand Exchange Reactions on Gold Nanoparticles","volume":"56","author":"Luo","year":"2017","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.intimp.2025.114033_b0190","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ejpb.2021.05.024","article-title":"Freeze-drying of nanoparticles: How to overcome colloidal instability by formulation and process optimization","volume":"165","author":"Trenkenschuh","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.intimp.2025.114033_b0195","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.carbpol.2018.02.010","article-title":"Improving the stability of thyme essential oil solid liposome by using \u03b2-cyclodextrin as a cryoprotectant","volume":"188","author":"Lin","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.intimp.2025.114033_b0200","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejpb.2021.10.014","article-title":"Impact of formulation on the quality and stability of freeze-dried nanoparticles","volume":"169","author":"Luo","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.intimp.2025.114033_b0205","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.foodchem.2017.10.141","article-title":"Freeze-dried phosphatidylcholine liposomes encapsulating various antioxidant extracts from natural waste as functional ingredients in surimi gels","volume":"245","author":"Mar\u00edn","year":"2018","journal-title":"Food Chem."},{"issue":"3","key":"10.1016\/j.intimp.2025.114033_b0210","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3390\/pharmaceutics10030139","article-title":"Lyophilization of Liposomal Formulations: Still Necessary, Still Challenging","volume":"10","author":"Franz\u00e9","year":"2018","journal-title":"Pharmaceutics."},{"issue":"7","key":"10.1016\/j.intimp.2025.114033_b0215","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3390\/pharmaceutics13071023","article-title":"Post-Processing Techniques for the Improvement of Liposome Stability","volume":"13","author":"Yu","year":"2021","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.intimp.2025.114033_b0220","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1128\/JVI.03445-13","article-title":"Analysis of T cell responses during active varicella-zoster virus reactivation in human ganglia","volume":"88","author":"Abendroth","year":"2014","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114033_b0225","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/pharmaceutics13030390","article-title":"The Effect of a TLR4 Agonist\/Cationic Liposome Adjuvant on Varicella-Zoster Virus Glycoprotein E Vaccine Efficacy: Antigen Presentation, Uptake, and Delivery to Lymph Nodes","volume":"13","author":"Wui","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.intimp.2025.114033_b0230","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jconrel.2015.04.010","article-title":"Cationic liposome-hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens","volume":"208","author":"Fan","year":"2015","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.intimp.2025.114033_b0235","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3390\/pharmaceutics13040520","article-title":"Advances in Lipid-Based Nanoparticles for Cancer Chemoimmunotherapy","volume":"13","author":"Wang","year":"2021","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.intimp.2025.114033_b0240","doi-asserted-by":"crossref","first-page":"6416","DOI":"10.1021\/acsnano.7b02884","article-title":"General Strategy for Direct Cytosolic Protein Delivery via Protein-Nanoparticle Co-engineering","volume":"11","author":"Mout","year":"2017","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.intimp.2025.114033_b0245","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1021\/acsnano.6b07258","article-title":"Programmed Self-Assembly of Hierarchical Nanostructures through Protein-Nanoparticle Coengineering","volume":"11","author":"Mout","year":"2017","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.intimp.2025.114033_b0250","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/anie.201106410","article-title":"Polymersomes in polymersomes: multiple loading and permeability control","volume":"51","author":"Marguet","year":"2012","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"1","key":"10.1016\/j.intimp.2025.114033_b0255","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/pharmaceutics8010007","article-title":"Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators","volume":"8","author":"Tandrup Schmidt","year":"2016","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.intimp.2025.114033_b0260","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2019.04.025","article-title":"Liposomes used as a vaccine adjuvant-delivery system: From basics to clinical immunization","volume":"303","author":"Wang","year":"2019","journal-title":"J. Control. Release"},{"issue":"42","key":"10.1016\/j.intimp.2025.114033_b0265","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.1016\/j.vaccine.2014.07.081","article-title":"Lymphatic-targeted cationic liposomes: a robust vaccine adjuvant for promoting long-term immunological memory","volume":"32","author":"Wang","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.intimp.2025.114033_b0270","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41541-024-00865-5","article-title":"Potent and long-lasting humoral and cellular immunity against varicella zoster virus induced by mRNA-LNP vaccine","volume":"9","author":"Bhattacharya","year":"2024","journal-title":"npj Vaccines"},{"key":"10.1016\/j.intimp.2025.114033_b0275","article-title":"Polymersomes decorated with SARS-CoV-2 spike protein receptor binding domain elicit robust humoral and cellular immunity","volume":"8","author":"Volpatti","year":"2021","journal-title":"ACS Cent. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2025.114033_b0280","doi-asserted-by":"crossref","first-page":"15754","DOI":"10.1021\/acsnano.1c01243","article-title":"Polymersomes as Stable Nanocarriers for a Highly Immunogenic and Durable SARS-CoV-2 Spike Protein Subunit Vaccine","volume":"15","author":"Lam","year":"2021","journal-title":"ACS Nano"},{"issue":"44","key":"10.1016\/j.intimp.2025.114033_b0285","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1016\/j.vaccine.2019.09.031","article-title":"VZV-specific cell-mediated immunity, but not humoral immunity, correlates inversely with the incidence of herpes zoster and the severity of skin symptoms and zoster-associated pain: The SHEZ study","volume":"37","author":"Asada","year":"2019","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.intimp.2025.114033_b0290","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3390\/vaccines9040310","article-title":"Immunogenicity of Varicella-Zoster Virus Glycoprotein E Formulated with Lipid Nanoparticles and Nucleic Immunostimulators in Mice","volume":"9","author":"Cao","year":"2021","journal-title":"Vaccines (basel)"},{"issue":"2","key":"10.1016\/j.intimp.2025.114033_b0295","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.immuni.2021.01.008","article-title":"COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses","volume":"54","author":"Bonifacius","year":"2021","journal-title":"Immunity"},{"issue":"49","key":"10.1016\/j.intimp.2025.114033_b0300","doi-asserted-by":"crossref","first-page":"eabd6160","DOI":"10.1126\/sciimmunol.abd6160","article-title":"SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection","volume":"5","author":"Altmann","year":"2020","journal-title":"Sci. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925000220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925000220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:58:24Z","timestamp":1778619504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":60,"alternative-id":["S1567576925000220"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114033","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A VZV-gE subunit vaccine decorated with mPLA elicits protective cellular immmune responses against varicella-zoster virus","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114033"}}